Unknown

Dataset Information

0

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.


ABSTRACT: The activation of the transcription factor hypoxia-inducible factor-1 (HIF-1) plays an essential role in tumor development, tumor progression, and resistance to chemo- and radiotherapy. In order to identify compounds targeting the HIF pathway, a small molecule library was screened using a luciferase-driven HIF-1 reporter cell line under hypoxia. The high-throughput screening led to the identification of a class of aminoalkyl-substituted compounds that inhibited hypoxia-induced HIF-1 target gene expression in human lung cancer cell lines at low nanomolar concentrations. Lead structure BAY 87-2243 was found to inhibit HIF-1? and HIF-2? protein accumulation under hypoxic conditions in non-small cell lung cancer (NSCLC) cell line H460 but had no effect on HIF-1? protein levels induced by the hypoxia mimetics desferrioxamine or cobalt chloride. BAY 87-2243 had no effect on HIF target gene expression levels in RCC4 cells lacking Von Hippel-Lindau (VHL) activity nor did the compound affect the activity of HIF prolyl hydroxylase-2. Antitumor activity of BAY 87-2243, suppression of HIF-1? protein levels, and reduction of HIF-1 target gene expression in vivo were demonstrated in a H460 xenograft model. BAY 87-2243 did not inhibit cell proliferation under standard conditions. However under glucose depletion, a condition favoring mitochondrial ATP generation as energy source, BAY 87-2243 inhibited cell proliferation in the nanomolar range. Further experiments revealed that BAY 87-2243 inhibits mitochondrial complex I activity but has no effect on complex III activity. Interference with mitochondrial function to reduce hypoxia-induced HIF-1 activity in tumors might be an interesting therapeutic approach to overcome chemo- and radiotherapy-resistance of hypoxic tumors.

SUBMITTER: Ellinghaus P 

PROVIDER: S-EPMC3892793 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.

Ellinghaus Peter P   Heisler Iring I   Unterschemmann Kerstin K   Haerter Michael M   Beck Hartmut H   Greschat Susanne S   Ehrmann Alexander A   Summer Holger H   Flamme Ingo I   Oehme Felix F   Thierauch Karlheinz K   Michels Martin M   Hess-Stumpp Holger H   Ziegelbauer Karl K  

Cancer medicine 20130820 5


The activation of the transcription factor hypoxia-inducible factor-1 (HIF-1) plays an essential role in tumor development, tumor progression, and resistance to chemo- and radiotherapy. In order to identify compounds targeting the HIF pathway, a small molecule library was screened using a luciferase-driven HIF-1 reporter cell line under hypoxia. The high-throughput screening led to the identification of a class of aminoalkyl-substituted compounds that inhibited hypoxia-induced HIF-1 target gene  ...[more]

Similar Datasets

| S-EPMC7115760 | biostudies-literature
| S-EPMC5095872 | biostudies-literature
| S-EPMC4018126 | biostudies-literature
| S-EPMC6512007 | biostudies-literature
| S-EPMC10108358 | biostudies-literature
| S-EPMC8591729 | biostudies-literature
| S-EPMC10009755 | biostudies-literature
| S-EPMC6282584 | biostudies-literature
| S-EPMC4297600 | biostudies-literature
| S-EPMC7463258 | biostudies-literature